Quick filters:
Open Data
Open Code
Pre-registered
Funding Declared
COI Declared
Open Access
Clear Filters
Single Ad26.COV2.S booster dose following two doses of BBIBP-CorV vaccine against SARS-CoV-2 infection in adults: Day 2…
Muangnoicharoen S; Wiangcharoen R; Nanthapisal S; Kamolratakul S; Lawpoolsri S; Jongkaewwattana A; Thitithanyanont A; Luvira V; Chinwangso P; Thanthamnu N; Chantratita N; Lim JK; Anh Wartel T; Excler JL; Ryser MF; Leong C; Mak TK; Pitisuttithum P.
Vaccine
(Unknown)
Published: 2023
Evaluation of potential adverse events following COVID-19 mRNA vaccination among adults aged 65 years and older: Two se…
Shoaibi A; Lloyd PC; Wong HL; Clarke TC; Chillarige Y; Do R; Hu M; Jiao Y; Kwist A; Lindaas A; Matuska K; McEvoy R; Ondari M; Parulekar S; Shi X; Wang J; Lu Y; Obidi J; Zhou CK; Kelman JA; Forshee RA; Anderson SA.
Vaccine
(Unknown)
Published: 2023
A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically ina…
Puthanakit T; Chokephaibulkit K; Chaithongwongwatthana S; Bhat N; Tang Y; Anugulruengkitt S; Chayachinda C; Anuwutnavin S; Lapphra K; Rungmaitree S; Tawan M; Andi-Lolo I; Holt R; Fortuna L; Kerdsomboon C; Yuwaree V; Mansouri S; Thai PH; Innis BL.
Vaccine
(Unknown)
Published: 2023
Immune response enhancement with GLS-5310 DNA primary vaccine against SARS-CoV-2 followed by administration of an mRNA …
Kim WJ; Roberts CC; Song JY; Yoon JG; Seong H; Hyun HJ; Lee H; Gil A; Oh Y; Park JE; Lee JE; Jeon B; Kane D; Spruill S; Kudchodkar SB; Muthumani K; Park YK; Kwon I; Maslow JN.
Vaccine
(Unknown)
Published: 2023
Upscaling vaccine manufacturing capacity - key bottlenecks and lessons learned.
Vaccine
(Unknown)
Published: 2023
Immunogenicity and safety of a fourth homologous dose of NVX-CoV2373.
Alves K; Plested JS; Galbiati S; Chau G; Cloney-Clark S; Zhu M; Kalkeri R; Patel N; Smith K; Marcheschi A; Pfeiffer S; McFall H; Smith G; Glenn GM; Dubovsky F; Mallory RM; Novavax 2019nCoV-101 Study Group.
Vaccine
(Unknown)
Published: 2023
Evaluation of association of anti-PEG antibodies with anaphylaxis after mRNA COVID-19 vaccination.
Zhou ZH; Cortese MM; Fang JL; Wood R; Hummell DS; Risma KA; Norton AE; KuKuruga M; Kirshner S; Rabin RL; Agarabi C; Staat MA; Halasa N; Ware RE; Stahl A; McMahon M; Browning P; Maniatis P; Bolcen S; Edwards KM; Su JR; Dharmarajan S; Forshee R; Broder KR; Anderson S; Kozlowski S.
Vaccine
(Unknown)
Published: 2023